vVARDIS Holding AG has taken a significant step toward its initial public offering (IPO) by filing an amended registration statement with the Securities and Exchange Commission (SEC) on November 6, 2026. This filing, designated as F-1/A, outlines the company’s plan to offer 9,523,810 Class A ordinary shares at an expected price range of $21.00 to $24.00 per share. The move is crucial for the company as it seeks to solidify its presence in the surgical and medical instruments sector.

Founded in Switzerland, vVARDIS Holding AG operates in the Surgical & Medical Instruments & Apparatus industry, classified under SIC code 3841. The company has recently been preparing for its IPO, with earlier filings dating back to October 9, 2026, when it submitted its initial registration statement. The latest filing indicates a strong commitment to securing funding for future growth and expansion.

The amended registration statement reveals that the underwriters may purchase an additional 1,428,571 Class A ordinary shares from selling shareholders within 30 days to cover over-allotments. Notably, the company will convert its existing share capital into two classes of ordinary shares: Class A and Class B. This conversion allows each Class B share to carry ten times the voting power of a Class A share, effectively giving the founders, Haley and Goly Abivardi, significant control over company decisions.

This IPO could have a substantial impact on various stakeholders, including potential investors and competitors in the surgical and medical instruments industry. The filing underscores vVARDIS Holding AG's ambition to enhance its market presence and attract a broader investor base as it prepares for its public debut.

Looking ahead, vVARDIS Holding AG has not specified the exact timeline for the commencement of the public sale of its shares. However, the company is poised to move forward as soon as practicable following the effective date of the registration statement. The filing does not indicate what happens next, but it highlights the company's readiness to engage with the public market.